• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ORTHO CLINICAL DIAGNOSTICS VITROS IMMUNODIAGNOSTIC PRODUCTS NT-PROBNP REAGENT PACK; IN VITRO DIAGNOSTICS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ORTHO CLINICAL DIAGNOSTICS VITROS IMMUNODIAGNOSTIC PRODUCTS NT-PROBNP REAGENT PACK; IN VITRO DIAGNOSTICS Back to Search Results
Catalog Number 6802156
Device Problem High Readings (2459)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 09/26/2019
Event Type  malfunction  
Manufacturer Narrative
The investigation determined that discordant, higher than expected vitros ntbnp results were obtained from a single patient sample when tested using vitros ntbnp lot#: 2170 on a vitros 5600 integrated system.The results were discordant when compared to the vitros ntbnp lot 2140 result from the same patient sample.The most likely cause of the discordant, higher than expected vitros ntbnp results is a patient sample issue, caused by a combination of hemolysis, fibrin and turbidity in the patient sample.The customer stated that the patient sample was visibly hemolyzed when the sample was observed following testing on (b)(6) 2019.Also, strands of fibrin were found in the patient sample when the sample was observed on 26 september 2019, indicating pre-analytical sample handling errors prior to testing.According to the turbidity index of the patient sample, the sample was more turbid on (b)(6) 2019 following storage in a fridge following testing on 25 september 2019.Pre-analytical sample processing could not be ruled out as a contributing factor as the customer is was not established whether the customer was following the sample collection device manufacture¿s recommendation for sample centrifugation.Improper pre-analytical sample handling could have contributed to this event.It is possible that cellular debris, due to poor sample preparation, was present in the affected sample, although this could not be confirmed.A vitros ntbnp lot: 2170 reagent issue cannot be ruled out as a contributor to the event, as the higher than expected results were both obtained on lot: 2170, and the expected result was obtained on vitros ntbnp lot 2140.Additionally, limited quality control data was available to evaluate the performance of vitros ntbnp lot: 2170 leading up to the event, as the discordant results were obtained on the first day of use of vitros ntbnp lot: 2170, and the customer reverted to vitros ntbnp lot 2140 following the event.However, quality control results on the day of the event were within acceptable guidelines and ongoing tracking and trending of complaint data has not identified any signals to suggest there is a systemic quality issue with vitros ntbnp reagent lot: 2170.An instrument issue is an unlikely contributor to the event, as precision testing on the vitros 5600 integrated system indicated that the instrument was performing as expected around the time of the event.
 
Event Description
A customer contacted the ortho clinical diagnostics (ortho) technical solution center (tsc) to report discordant, higher than expected vitros nt ¿ probnp (ntbnp) lot 2170 patient sample results when tested on a vitros 5600 integrated system.The results were discordant compared to the results from the same patient same tested using vitros ntbnp lot#: 2140.Vitros ntbnp lot 2170 results of 1333.08 pg/ml and 553.18 pg/ml versus vitros ntbnp lot#: 2140 result of 47.98 pg/ml.Biased results of the magnitude and direction observed may lead to inappropriate physician action if they were to occur undetected.The higher than expected vitros ntbnp results were not reported from the laboratory.Ortho has not been made aware of any allegation of patient harm as a result of this event.This report corresponds to ortho clinical diagnostics inc.Complaint number (b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VITROS IMMUNODIAGNOSTIC PRODUCTS NT-PROBNP REAGENT PACK
Type of Device
IN VITRO DIAGNOSTICS
Manufacturer (Section G)
ORTHO CLINICAL DIAGNOSTICS
felindre meadows
pencoed
bridgend, wales CF35 5PZ
UK   CF35 5PZ
Manufacturer Contact
james a stevens
100 indigo creek drive
rochester, NY 14626
5854533000
MDR Report Key9232719
MDR Text Key219509839
Report Number3007111389-2019-00167
Device Sequence Number1
Product Code NBC
Combination Product (y/n)N
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional
Reporter Occupation Other
Type of Report Initial
Report Date 10/24/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date01/04/2020
Device Catalogue Number6802156
Device Lot Number2170
Was Device Available for Evaluation? Yes
Initial Date Manufacturer Received 09/26/2019
Initial Date FDA Received10/24/2019
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured07/17/2019
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage N
Patient Sequence Number1
-
-